Insights from 2025 ASCO® GI Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ASCO® GI 2025 Insights: Preliminary Safety and Efficacy of Upfront FOLFOXIRI + Bevacizumab + Cadonilimab in pMMR/MSS mCRC - Ph2 SYLT-026 Study
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Rongbo Lin
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Rongbo Lin
Comments 0
Login to view comments.
Click here to Login
